AIM ImmunoTech Inc (AIM)
0.2117
+0.01
(+5.85%)
USD |
NYAM |
Nov 21, 16:00
0.2121
0.00 (0.00%)
After-Hours: 05:56
AIM ImmunoTech Total Liabilities (Quarterly): 10.68M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.68M |
| June 30, 2024 | 9.613M |
| March 31, 2024 | 11.36M |
| December 31, 2023 | 9.147M |
| September 30, 2023 | 5.259M |
| June 30, 2023 | 3.482M |
| March 31, 2023 | 2.473M |
| December 31, 2022 | 2.02M |
| September 30, 2022 | 3.59M |
| June 30, 2022 | 2.104M |
| March 31, 2022 | 0.854M |
| December 31, 2021 | 0.82M |
| September 30, 2021 | 1.033M |
| June 30, 2021 | 1.19M |
| March 31, 2021 | 3.122M |
| December 31, 2020 | 3.29M |
| September 30, 2020 | 3.052M |
| June 30, 2020 | 3.131M |
| March 31, 2020 | 7.296M |
| December 31, 2019 | 7.312M |
| September 30, 2019 | 8.646M |
| June 30, 2019 | 7.26M |
| March 31, 2019 | 12.04M |
| December 31, 2018 | 8.671M |
| September 30, 2018 | 8.731M |
| Date | Value |
|---|---|
| June 30, 2018 | 6.589M |
| March 31, 2018 | 6.06M |
| December 31, 2017 | 5.504M |
| September 30, 2017 | 4.684M |
| June 30, 2017 | 5.776M |
| March 31, 2017 | 3.915M |
| December 31, 2016 | 3.375M |
| September 30, 2016 | 4.945M |
| June 30, 2016 | 4.429M |
| March 31, 2016 | 3.092M |
| December 31, 2015 | 2.433M |
| September 30, 2015 | 3.327M |
| June 30, 2015 | 3.102M |
| March 31, 2015 | 3.821M |
| December 31, 2014 | 4.436M |
| September 30, 2014 | 4.273M |
| June 30, 2014 | 4.181M |
| March 31, 2014 | 3.017M |
| December 31, 2013 | 2.569M |
| September 30, 2013 | 10.73M |
| June 30, 2013 | 9.999M |
| March 31, 2013 | 10.28M |
| December 31, 2012 | 13.00M |
| September 30, 2012 | 11.97M |
| June 30, 2012 | 7.575M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.82M
Minimum
Dec 2021
11.36M
Maximum
Mar 2024
4.541M
Average
3.210M
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 62.68M |
| Protalix BioTherapeutics Inc | 29.13M |
| Electromed Inc | 7.427M |
| Xtant Medical Holdings Inc | 53.16M |
| Armata Pharmaceuticals Inc | 149.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.59M |
| Shareholders Equity (Quarterly) | 2.912M |
| Debt to Equity Ratio | 0.9382 |
| Current Ratio | 0.7495 |
| Net Debt Paydown Yield | -3.45% |